Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Ms. Louise KooijCAO | -65,00k | 1,67M | Derivative Exercise and Sale | 10,00 - 35,69 | 2,35k | - |
| 2026-05-08 | Bain Capital Life Sciences Investors, LLCUnternehmen | -3,50M | 131,55M | Verkauf | 37,22 - 39,98 | 2,17M | -61,69% |
| 2026-03-11 | Dr. Louis G. LangeIndependent Non-Executive Director | -44,62k | 1,36M | Verkauf | 30,41 - 31,23 | 2,32k | -95,06% |
| 2026-03-09 | Dr. Louis G. LangeIndependent Non-Executive Director | 44,62k | 513,12k | Derivative Exercise and Retained Stock | 11,50 | 46,94k | 1.923,23% |
| 2026-03-06 | Dr. Louis G. LangeIndependent Non-Executive Director | -28,19k | 828,95k | Verkauf | 29,41 | 46,94k | -37,52% |
| 2026-03-05 | Dr. Johannes Jacob Pieter KasteleinFounder, Chief Scientific Officer, Member of Executive Board & Director | -300,00k | 9,09M | Derivative Exercise and Sale | 30,29 - 30,32 | 74,64k | - |
| 2026-03-02 | Dr. Michael Harvey DavidsonCEO, President & Executive Director | -443,71k | 14,75M | Derivative Exercise and Sale | 33,25 | 296,51k | - |
| 2026-02-24 | Dr. Michael Harvey DavidsonCEO, President & Executive Director | -306,29k | 10,58M | Derivative Exercise and Sale | 33,63 - 36,68 | 296,51k | - |
| 2026-02-20 | Dr. Johannes Jacob Pieter KasteleinFounder, Chief Scientific Officer, Member of Executive Board & Director | -45,48k | 1,61M | Verkauf | 35,00 - 35,46 | 74,64k | -37,86% |
| 2026-01-27 | Ms. Louise KooijCAO | -72,43k | 1,55M | Derivative Exercise and Sale | 10,90 - 32,62 | 2,35k | - |
| 2026-01-23 | Ms. Louise KooijCAO | -72,57k | 1,62M | Derivative Exercise and Sale | 10,90 - 34,37 | 2,35k | - |
| 2026-01-20 | Mr. Mayur Amrat SomaiyaCFO | -100,00k | 2,33M | Derivative Exercise and Sale | 9,26 - 33,80 | 7,55k | - |
| 2026-01-07 | Dr. Michael Harvey DavidsonCEO, President & Executive Director | -11,58k | 0,00 | Verkauf | - | 296,51k | -3,76% |
| 2026-01-05 | Dr. Johannes Jacob Pieter KasteleinFounder, Chief Scientific Officer, Member of Executive Board & Director | -6,00k | 199,50k | Verkauf | 33,25 | 120,12k | -4,76% |
| 2026-01-05 | Ms. Louise KooijCAO | -2,65k | 88,01k | Verkauf | 33,25 | 2,35k | -52,94% |
| 2026-01-05 | Mr. Mayur Amrat SomaiyaCFO | -5,12k | 170,17k | Verkauf | 33,25 | 7,55k | -40,40% |
| 2025-12-23 | Ms. Louise KooijCAO | -145,00k | 3,74M | Derivative Exercise and Sale | 10,00 - 36,21 | 15,00k | - |
| 2025-02-12 | Bain Capital Life Sciences Investors, LLCUnternehmen | -4,80M | 168,48M | Verkauf | 35,10 | 297,56k | -94,16% |
| 2025-09-17 | Frazier Life Sciences Management, LPUnternehmen | 21,46k | 508,55k | Kauf | 23,70 | 12,90M | 0,17% |
| 2025-09-17 | Frazier Life Sciences Public Overage Fund, L.P.Unternehmen | 4,71k | 111,70k | Kauf | 23,70 | 0,00 | -100,00% |
| 2025-11-01 | Frazier Life Sciences Public Overage Fund, L.P.Unternehmen | -2,99M | 0,00 | Verkauf | - | 0,00 | -100,00% |
| 2025-11-01 | Frazier Life Sciences Management, LPUnternehmen | 2,99M | 0,00 | Kauf | - | 12,90M | 30,16% |
| 2025-09-15 | Frazier Life Sciences Management, LPUnternehmen | 660,00 | 15,64k | Kauf | 23,70 | 13,65M | 0,00% |
| 2025-09-09 | Ms. Louise KooijCAO | -150,00k | 2,37M | Derivative Exercise and Sale | 10,00 - 26,11 | 15,00k | - |
| 2025-09-08 | Frazier Life Sciences Management, LPUnternehmen | 1,26k | 31,49k | Kauf | 24,99 | 13,65M | 0,01% |
| 2025-09-03 | Ms. Louise KooijCAO | -18,07k | 453,45k | Verkauf | 25,09 | 0,00 | -100,00% |
| 2025-09-02 | Ms. Louise KooijCAO | 18,07k | 0,00 | Derivative Exercise and Retained Stock | - | 33,07k | 120,49% |
| 2025-08-25 | Ms. Louise KooijCAO | -8,27k | 205,57k | Verkauf | 24,86 | 0,00 | -100,00% |
| 2025-08-21 | Dr. Johannes Jacob Pieter KasteleinFounder, Chief Scientific Officer, Member of Executive Board & Director | -100,00k | 2,47M | Verkauf | 24,29 - 25,49 | 114,78k | -46,56% |
| 2025-08-11 | Frazier Life Sciences Management, LPUnternehmen | 2,19k | 52,54k | Kauf | 23,98 | 59,65k | 3,81% |
| 2025-08-11 | Frazier Life Sciences Management, LPUnternehmen | 471,00 | 11,29k | Kauf | 23,98 | 9,85M | 0,00% |
| 2025-08-08 | Forbion Capital Partners B.V.Unternehmen | -53,31k | 1,35M | Verkauf | 25,00 - 25,28 | 5,93M | -0,89% |
| 2025-07-15 | Mr. Douglas F. KlingCOO | -98,61k | 1,02M | Derivative Exercise and Sale | 10,90 - 22,12 | 0,00 | - |
| 2025-06-24 | Frazier Life Sciences Management, LPUnternehmen | 3,78k | 69,47k | Kauf | 18,26 - 18,43 | 9,29M | 0,04% |
| 2025-06-16 | Mr. Douglas F. KlingCOO | -100,00k | 909,43k | Derivative Exercise and Sale | 10,00 - 19,75 | 0,00 | - |
| 2025-06-16 | Frazier Life Sciences Management, LPUnternehmen | 8,58k | 167,38k | Kauf | 19,50 | 9,29M | 0,09% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
